AAV5-hRKp.RPGR

· Janssen Pharmaceutical K.K.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AAV5-hRKp.RPGR, covering 2026-04-13 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa [Phase 3]